In DMD patient-derived myoblasts, sPIF overexpression promotes myoblast differentiation and decreases expression of COL1A1, COL1A2, and TGF-β, along with increases in the expression of the dystrophin homolog, utrophin protein. The gene discussed is COL1A1; the disease is Duchenne muscular dystrophy.